Hadani, Samera S.
HRN: 18-89-39 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFTRIAXONE 1G (VIAL)
05/24/2022
05/24/2022
IVT
1g
LD
OR
Waiting Final Action
05/25/2022
CEFUROXIME 500MG (TAB)
05/25/2022
05/31/2022
ORAL
500mg
Q12
S/P Exlap
Waiting Final Action